What drives us is the idea that we can design a single drug to treat obesity and simultaneously mitigate the risk of developing a long list of health problems plaguing society,” says Krishna Kumar.

Insulin itself is a peptide hormone, and newer peptide analogs have ... even triple agonists that simultaneously target multiple receptors, such as GLP-1, glucose-dependent insulinotropic ...

Count podcast host Joe Rogan, 57, among the fans of BPC-157 — he reported that it cleared up his elbow tendonitis in just two ...

Your doctor will check to see if your tumor has hormone receptors. If it does, they may call it "hormone-receptor positive," “ER-positive,” or “PR-positive.” For advanced cases ...

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Retatrutide (LY3437943; Eli Lilly) is a single peptide conjugated to a fatty diacid moiety and has agonism toward the GIP, GLP-1, and GCG receptors. As compared with the endogenous receptor ...

A synthetic peptide that is proposed to mimic ... intake patterns and may potentially decrease hunger hormone signalling. Melanocortin receptors are part of the machinery that controls blood ...